Skip to main content
Erschienen in: BMC Public Health 1/2003

Open Access 01.12.2003 | Research article

Effects of Greek orthodox christian church fasting on serum lipids and obesity

verfasst von: Katerina O Sarri, Nikolaos E Tzanakis, Manolis K Linardakis, George D Mamalakis, Anthony G Kafatos

Erschienen in: BMC Public Health | Ausgabe 1/2003

Abstract

Background

No study to date has focused on the impact of Greek Orthodox Christian fasting on serum lipoproteins and obesity yet.

Methods

120 Greek adults were followed longitudinally for one year. Sixty fasted regularly in all fasting periods (fasters) and 60 did not fast at all (controls). The three major fasting periods under study were: Christmas (40 days), Lent (48 days) and Assumption (August, 15 days). A total of 6 measurements were made during one year including pre- and end-fasting blood collection, serum lipoprotein analyses and anthropometric measurements.

Results

Statistically significant end-fasting total and LDL cholesterol differences were found in fasters. Fasters compared to controls presented 12.5% lower end-total cholesterol (p < 0.001), 15.9% lower end-LDL cholesterol (p < 0.001) and 1.5% lower end-BMI (p < 0.001). The end- LDL/HDL ratio was lower in fasters (6.5%, p < 0.05) while the change in end- HDL cholesterol in fasters (4.6% decline) was not significant. Similar results were found when the pre- and end-fasting values of fasters were compared. No change was found in control subjects.

Conclusions

Adherence to Greek Orthodox fasting periods contributes to a reduction in the blood lipid profile including a non-significant reduction in HDL cholesterol and possible impact on obesity.
Hinweise

Competing interests

None declared.

Authors' contributions

Author K.S mainly organized and performed the study, and drafted the manuscript. Author N.T participated in the design of the study and supervised the manuscript. Author M.L performed the statistical analyses. Author G.M performed part of the statistical analysis. Author A.K conceived of the study, participated in its design, and supervised the study and the manuscript.

Background

Fasting, the voluntary abstention from all restricted foods, is a feature of many religions, and the putative health benefits have attracted both scientific and popular interest. Commonly, religious doctrines proscribe foods from animal sources permanently or for particular periods.
There are several religions, such as Hinduism, Buddhism, Judaism, Islam, Seventh-Day-Adventism that have often been studied regarding their relation to health [114]. However, the studies on Orthodox Christianity are very limited.
Orthodox Christian holy books recommend a total of 180–200 days of fasting per year. The faithful are advised to avoid olive oil, meat, fish, milk and dairy products every Wednesday and Friday throughout the year. Additionally, there are three principal fasting periods per year: i) a total of 40 days preceding Christmas (meat, dairy products and eggs are not allowed, while fish and olive oil are allowed except on Wednesdays and Fridays), ii) a period of 48 days preceding Easter (Lent). During Lent fish is allowed only two days whereas meat, dairy products and eggs are not allowed. Olive oil consumption is allowed only at weekends, iii) a total of 15 days in August (the Assumption) when the same dietary rules apply as for Lent with the exception of fish consumption which is allowed only on August 6th. Seafood such as shrimps, squid, cuttlefish, octopus, lobsters, crabs as well as snails are allowed on all fasting days throughout the year. The Greek Orthodox fasting practices can therefore be characterized as requiring a periodic vegetarian diet including fish and seafood.
The variant of vegetarianism followed during fasting periods by Orthodox Christians, with a diet of vegetables, legumes, nuts, fruits, olives, bread, snails and seafood, is a type of the so-called Mediterranean diet [15, 16]. To date little is known as to the effects of this 'hidden' element of the traditional Orthodox Christian diet on health and no data exist on the effect of Orthodox Christianity's dietary rules on blood lipid levels and obesity. The objective of this study was therefore to assess the effects of intermittent short-term religious fasting, according to the dietary rules of the Orthodox Christian Church, on blood lipoprotein profile and the prevalence of obesity.

Methods

Subjects

The subjects of this study were selected from an adult population in the region of Heraklion, Crete. One hundred-twenty Orthodox Christians were asked to participate in this study. Sixty individuals (31 males, 29 females), mean age (x ± SD) 41 ± 12 years, fasted regularly according to the dietary rules and the fasting periods of the Christian Orthodox Church. Fasters had been practicing the fasting rituals for a mean of 20 ± 14 years. Another group of sixty subjects (24 males, 36 females), mean age (x ± SD) 38 ± 9 years, were control subjects that did not fast. Among the fasting group, 20 were lay persons (fasted for 13 ± 10 years) and 40 were under religious order (fasted for 23 ± 15 years): 19 nuns living in a convent and 21 priests living with their families in community parishes. The family history of each subject was recorded with regard to diabetes, CHD, smoking, hormonal disturbances and drug intake.

Study design

Three pairs of measurements were made over a 1-year period (2000–2001), coinciding with the beginning and end of each of the three major fasting periods of the Christian Orthodox Church: Christmas, Lent and the Assumption. All measurements were made between 8.00–10.00 am and they included fasting blood collection, anthropometric measurements and the completion of questionnaires.

Questionnaires

All subjects signed informed consent forms and completed questionnaires on fasting, health habits (coffee and alcohol consumption, smoking), certain items of personal data (marital status, educational level), physical activity, dietary habits (24 h recall, 3-day dietary record). Fasters were defined as those who fasted regularly during all three principal fasting periods, while current smokers as those who smoked at least one cigarette per day.

Anthropometric variables

Body weight was measured all six times by a digital scale (Seca, Hamburg, Germany, Model 770) with an accuracy of ± 100 g. Subjects were weighed barefoot in very light clothing. Standing height was measured once without shoes to the nearest 0.5 cm with the use of a stadiometer with the shoulders in relaxed position and arms hanging freely. Body Mass Index (BMI) was calculated by dividing weight (kg) by height squared (m2). Waist and hip circumferences were measured twice, at the first and sixth measurement of the study [17]. Blood pressure (BP) was measured all six times in the right arm with a traditional sphygmomanometer. Three seated BP measurements were taken for each subject spaced two minutes apart.

Biochemical assays

Serum lipoprotein concentrations were always determined after 12 h of fasting. Blood samples were transferred to the University hospital of Crete in tanks containing ice packs that maintained the temperature at 3–4°C. Total cholesterol was determined by Allain's method [18], HDL-C was measured by the heparin-manganese precipitation method [19] and triacylglycerols were determined using Fossati's method [20], while LDL-C was calculated as follows: LDL-C = TC - (HDL -C + TG/5) [21]. During the period October 2000 – September 2001 the coefficient of variation for the biochemical analysis of total cholesterol was 2,85%, for HDL was 5,40% and for triacylglycerols was 3,92%. DNA extraction was performed according to the method of Miller et al [22]. Apo E genotype was determined by PCR amplification and subsequent digestion with the restriction enzyme Hha I (New England Biolabs) as described by Reymer et al [23] in Harokopio University of Athens.

Statistical methods

Differences in gender, tobacco use, educational level and apolipoprotein E distribution were compared using χ2 analysis, while differences in age were compared by ANOVA analysis. Regression analysis was used to compare end-fasting lipid concentrations and BMI with age, sex, smoking, educational level, BMI, WHR, fasting and the pre-fasting values. The influence of fasting on end-fasting values was examined using ANCOVA analysis. Paired samples T-test and Mann-Whitney test were used to compare pre and end-fasting values in fasters.
Pre-fasting values comprise the mean of the three measurements that were made before the beginning of the Christmas, Lent and Assumption fasting periods, while end-fasting values are the mean of the three measurements that were made at the end of each one of the fasting periods.

Results

Demographic data on a hundred and twenty subjects are presented in Table 1. Sixty of the subjects were fasters (26% male, 24% female) with a mean age of 42 ± 12; the other sixty were control subjects (20% male, 30% female) with a mean age of 38 ± 9. There was no statistically significant difference in the age of the two groups (ANOVA). The subjects in the fasters group had been observing the fasting rituals for a mean of 20 ± 14 years. The rate of compliance with the fasting rules was 100%. All subjects in both groups did not suffer from any disease like thyroid, diabetes, cancer, cardiovascular diseases, and did not take any medication.
Table 1
Sociodemographic characteristics of the population.
 
FASTERS
CONTROLS
 
 
N (%)
n (%)
p
Sex
   
   Males
31 (52%)
24 (40%)
NSa
   Females
29 (48%)
36 (60%)
 
Age (years)c
42 ± 12
38 ± 9
NSb
Tobacco use
   
   Smokers
4 (7%)
33 (55%)
<0.001a
   Non-smokers
56 (93%)
27 (45%)
 
Educational level
   
   Higher
26 (43%)
14 (23%)
NSa
   Secondary
24 (40%)
34 (57%)
 
   Minimum school level / No education
10 (17%)
12 (20%)
 
a. Chi-square test (χ2) – Fisher exact test. b. ANOVA analysis. c. Values are means ± SD.
The levels of serum lipids, blood pressure and body measurements of all three periods for fasters and controls are presented in table 2.
Table 2
Levels of serum lipids, blood pressure and body measurements.
  
PRE-a
END-a
PRE-a
END-a
PRE-a
END-a
  
CHRISTMAS
EASTER
AUGUST
GLUCOSE (mmol/L)
Fb
4.97 ± 1.24 (59)
4.97 ± 1.39 (56)
4.65 ± 0.88 (49)
4.85 ± 1.13 (52)
5.16 ± 1.15 (47)
4.91 ± 1.11 (48)
 
Cb
4.75 ± 0.73 (60)
5.00 ± 1.25 (52)
4.76 ± 1.00 (54)
4.48 ± 0.68 (50)
4.62 ± 0.69 (41)
4.73 ± 0.87 (43)
TCHOL (mmol/L)
F
5.90 ± 1.20 (59)
5.45 ± 1.13 (56)
5.63 ± 1.15 (49)
5.05 ± 1.15 (52)
5.51 ± 1.17 (47)
5.12 ± 1.18 (48)
 
C
5.25 ± 1.02 (60)
5.24 ± 1.12 (52)
5.25 ± 1.09 (54)
5.08 ± 1.04 (50)
5.16 ± 1.02 (41)
5.48 ± 1.28 (43)
HDL (mmol/L)
F
1.22 ± 0.35 (59)
1.19 ± 0.27 (56)
1.17 ± 0.33 (49)
1.05 ± 0.29 (52)
1.23 ± 0.60 (47)
1.09 ± 0.28 (48)
 
C
1.18 ± 0.28 (60)
1.21 ± 0.28 (52)
1.36 ± 0.78 (54)
1.19 ± 0.29 (50)
1.20 ± 0.28 (41)
1.20 ± 0.33 (43)
TRIGL (mmol/L)
F
1.48 ± 0.95 (59)
1.39 ± 0.81 (56)
1.38 ± 0.72 (48)
1.43 ± 0.92 (52)
1.31 ± 0.82 (47)
1.36 ± 0.90 (48)
 
C
1.01 ± 0.42 (60)
1.02 ± 0.50 (52)
1.04 ± 0.42
   
LDL (mmol/L)
F
4.00 ± 1.06 (59)
3.62 ± 1.00 (56)
3.80 ± 0.99 (48)
3.33 ± 0.97 (51)
3.75 ± 1.03 (47)
3.41 ± 1.05 (48)
 
C
3.61 ± 0.91 (60)
3.56 ± 1.01 (52)
3.58 ± 0.99 (54)
3.37 ± 0.95 (50)
3.47 ± 0.94 (40)
3.77 ± 1.13 (43)
TC_HDL
F
5.21 ± 1.80 (59)
4.81 ± 1.48 (56)
5.10 ± 1.49 (49)
5.14 ± 1.71 (52)
5.04 ± 1.73 (47)
4.97 ± 1.54 (48)
 
C
4.70 ± 1.44 (60)
4.58 ± 1.50 (52)
4.37 ± 1.52 (54)
4.48 ± 1.35 (50)
4.52 ± 1.37 (41)
4.79 ± 1.42 (43)
WEIGHT (kg)
F
78.4 ± 16.4 (60)
77.0 ± 16.0 (57)
77.6 ± 16.0 (51)
76.0 ± 15.5 (52)
76.4 ± 16.1 (47)
75.4 ± 15.7 (49)
 
C
72.3 ± 15.8 (60)
74.1 ± 16.4 (52)
73.1 ± 16.2 (54)
72.7 ± 16.5 (50)
74.1 ± 17.0 (41)
74.7 ± 16.6 (43)
BMI (kg/m 2 )
F
28.6 ± 5.1 (59)
28.3 ± 5.1 (57)
28.2 ± 4.7 (51)
27.7 ± 4.8 (52)
27.7 ± 4.9 (47)
27.5 ± 4.7 (49)
 
C
25.8 ± 4.3 (60)
26.3 ± 4.5 (52)
25.9 ± 4.2 (54)
25.7 ± 4.4 (50)
26.1 ± 4.6 (41)
26.5 ± 4.8 (43)
SYST (mm Hg)
F
129 ± 18 (59)
128 ± 19 (57)
130 ± 21 (51)
129 ± 20 (52)
121 ± 16 (47)
117 ± 16 (49)
 
C
117 ± 14 (60)
109 ± 12 (52)
109 ± 13 (53)
106 ± 13 (50)
106 ± 15 (41)
107 ± 12 (43)
DIAST (mm Hg)
F
79 ± 8 (59)
79 ± 13 (57)
79 ± 13 (51)
81 ± 13 (52)
77 ± 12 (47)
73 ± 10 (49)
 
C
74 ± 11 (60)
69 ± 9 (52)
67 ± 10 (53)
67 ± 9 (50)
66 ± 11 (41)
66 ± 10 (43)
a. The values are presented as Mean ± SD (n) b. F = Fasters, C = Controls

Effect of fasting on end-fasting values

Multiple Linear Stepwise Regression Analysis indicated that fasting is a significant determinant for end-total cholesterol, end-LDL cholesterol, end-LDL/HDL ratio and end-BMI (Table 3), showing that fasters have lower levels of these variables.
Table 3
Effect of various variables including fasting on serum lipids and BMI.a
Dependent variables
Predictors
Beta
t
p
End Total Cholesterol
Pre-fasting TC
0.94
28.3
<0.001
 
Fasting
-0.24
-7.7
<0.001
 
WHR
0.19
3.2
0.002
 
Sex
-0.12
-2.1
0.037
End LDL cholesterol
Pre-fasting LDL-C
0.93
32.7
<0.001
 
Fasting
-0.23
-8.5
<0.001
 
WHR
0.2
3.9
<0.001
 
Sex
-0.12
-2.4
0.018
End HDL cholesterol
Pre-fasting HDL-C
0.74
10.9
<0.001
 
Sex
-0.24
-3.54
<0.001
End TC/HDL cholesterol
Pre TC:HDL-C
0.85
19.1
<0.001
 
Sex
0.17
3.9
<0.001
End LDL/HDL cholesterol
Pre LDL:HDL-C
0.88
21.0
<0.001
 
Sex
0.14
3.4
<0.001
 
Fasting
-0.1
-2.7
0.008
End fasting BMI
Pre-fasting BMI
1.0
115.9
<0.001
 
Fasting
-0.35
-4.06
<0.001
Multiple Linear Stepwise Regression Analysis with mean end-TC, end-LDL cholesterol, end-HDL cholesterol, end-BMI and the end-ratios of TC/HDL-C and LDL-C/HDL-C as the dependent variables. Independent variables were age, mean pre-BMI, fasting, smoking, sex, educational level, WHR, pre-ratios of TC/HDL-C and LDL-C/HDL-C and the pre-values of the dependent variables. Sex, fasting and smoking are dummies (sex: 0 = females and 1 = males, fasting: 0 = control subjects and 1 = fasters, smoking: 0 = smokers and 1 = non-smokers). a. The subjects that had all six measurements were included (n = 71).
Females have higher levels of end-HDL cholesterol while men have higher levels of end-TC/HDL and end-LDL/HDL ratios. Waist-to-hip ratio was positively related to end-total cholesterol and end-LDL cholesterol.

Comparisons of end-fasting values between the two groups

Comparisons of mean end-fasting values between fasters and controls are shown in Table 4. Mean end-TC, end-LDL and end-BMI were statistically lower (p < 0.001) in fasters compared to controls. Fasters presented 12.5% lower end-TC, 15.9% lower end-LDL cholesterol and 1.5% lower end-BMI compared to controls. Moreover, fasters had significantly lower LDL/HDL ratios (p < 0.05). All results were adjusted for age, sex, BMI and smoking.
Table 4
ANCOVA analysis. Effect of fasting on end-fasting mean ratios with covariates the respective pre-fasting mean ratios between fasters and control subjects.
End-fasting variables
FASTERS (n = 40)
CONTROLS (n = 31)
 
 
Mean
SEMa
Mean
SEMa
p
Glucose (mmol/L)
4.95
0.07
4.86
0.08
NS
Total cholesterol (mmol/L)
4.9
0.05
5.6
0.06
<0.001
HDL cholesterol (mmol/L)
1.1
0.03
1.2
0.03
NS
LDL cholesterol (mmol/L)
3.3
0.04
3.8
0.05
<0.001
Triglycerides (mmol/L)
1.27
0.05
1.25
0.06
NS
TC/HDL-Cb
4.7
0.08
5.0
0.1
NS
LDL-C/HDL-Cc
3.1
0.06
3.3
0.07
0.041
BMI (kg/m2)
27.0
0.06
27.4
0.07
<0.001
a. Standard Error of the Mean b. The ratio of total cholesterol: high-density lipoprotein c. The ratio of low-density lipoprotein: high-density lipoprotein The results are adjusted for age, BMI, sex, smoking

Comparisons of pre and end-fasting values in the fasters' group

The fasters who had 3 complete pairs of measurements were included in this analysis (Table 5). Paired samples T-test showed that fasters presented 9.1% decline in end- total cholesterol, 12.4% decline in end- LDL, 8.5% decline in end- HDL and 1.4% decline in end- BMI compared to their respective pre-values. All these differences were significant (p < 0.001). As for the ratios end- TC/HDL and end- LDL/HDL although they declined the changes were not significant. The same analysis was done in controls that presented no significant changes over the year. A further step was to categorize fasters in two subgroups: 1) nun-priests and 2) lay people and to compare their pre- and end- fasting values. Mann-Whitney test showed that the changes seen in fasters' group remained when each subgroup was analyzed separately though they were not significant. It was observed that between the major fasting periods studied (between the end of Christmas and the beginning of Lent; and between the end of Lent and the beginning of the Assumption fasting period) when fasters returned to their usual dietary habits (non-fasting periods) total cholesterol and LDL cholesterol were increased by 6% and 9% respectively.
Table 5
Pared samples T-test. Mean pre-fasting values compared to mean end-fasting values in the group of fasters (n = 43).
Variables
Pre-Fasting
End-Fasting
 
 
Mean
SEMa
Mean
SEMa
p
Glucose (mmol/L)
4.93
0.16
4.95
0.19
NS
Total cholesterol (mmol/L)
5.6
0.15
5.1
0.14
<0.001
HDL cholesterol (mmol/L)
1.2
0.04
1.1
0.04
<0.001
LDL cholesterol (mmol/L)
3.8
1.14
3.3
0.13
<0.001
Triglycerides (mmol/L)
1.41
0.13
1.36
0.09
NS
TC/HDL-Cb
5.0
0.2
4.9
0.2
NS
LDL-C/HDL-Cc
3.3
0.1
3.2
0.1
NS
BMI (kg/m2)
28
0.7
27.6
0.7
<0.001
a. Standard Error of the Mean b. The ratio of total cholesterol: high-density lipoprotein c. The ratio of low-density lipoprotein: high-density lipoprotein

Dietary data

Table 6 shows that at end-fasting periods fasters had 10% reduction in energy intake (EI), 17% reduction in total fat (%EI), 23% increase in carbohydrates (%EI) and 43.5% increase in fiber consumption, whereas the respective percentages for the controls are +7%, +1%, +1.7% and +3.3%. All the differences found between the two groups are significant.
Table 6
Ancova analysis. Dietary differences between fasters and controls among pre and end-fasting periods based on the 24 h dietary record.
  
Pre-fasting
End-fasting
Difference
p-value
  
Mean ± SE
 
Energy (kcal)
Fa
1788 ± 74
1596 ± 64
-182 ± 67
0.002
 
Ca
1906 ± 75
2043 ± 65
137 ± 69
 
Total fat (% of total energy intake)
F
38.3 ± 0.8
31.8 ± 1.1
-6.6 ± 1.1
<0.001
 
C
38.7 ± 0.8
39.1 ± 1.1
0.4 ± 1.1
 
Carbohydrates (% of total energy intake)
F
48.8 ± 1.1
59.8 ± 1.2
11.0 ± 1.3
<0.001
 
C
45.5 ± 1.1
44.6 ± 1.3
-0.8 ± 1.3
 
Protein (% of total energy intake)
F
13.8 ± 0.4
10.0 ± 0.4
-3.8 ± 0.6
<0.001
 
C
14.3 ± 0.4
14.4 ± 0.4
0.1 ± 0.6
 
Fiber (g per 1000 kcal)
F
11.5 ± 0.5
16.5 ± 0.5
5.0 ± 0.6
<0.001
 
C
9.2 ± 0.5
9.5 ± 0.5
0.3 ± 0.6
 
a. a. F = Fasters (n = 58), C = Controls (n = 56) The results were adjusted for sex, age and pre-BMI. In the analysis were included the subjects that had completed the 24 h dietary record in all 6 measurements.

Distribution of Apo E polymorphism

Subjects in this study were screened for the common apolipoprotein E (apoE) polymorphism, as genetic variation at the apoE locus has been shown to influence serum lipid responsiveness to dietary interventions and account for much of the interindividual variability in dietary response [24, 25] Several studies, for example, support the concept that the ε4 allele is associated with an increased cholesterol response to dietary manipulation, and that subjects carrying the ε4 allele are the most responsive to diets restricted in saturated fat and cholesterol [2427].
Fasters and control subjects were classified in three groups according to their apoE genotype: subjects homozygous for the common ε3 allele (apoE3/3 genotype, (38 fasters and 40 controls); subjects with the apoE2/3 genotype (nine fasters and four controls); carriers of the ε4 allele (apoE3/4 and apoE4/4 genotypes; four fasters and six controls, respectively). Chi-square analysis showed that apoE genotype distribution did not differ between fasters and controls (data not shown).

Discussion

The most important finding of this study is that most serum lipid variables decreased significantly over the fasting periods. Fasters, as compared to controls, had decreased levels of mean end- total cholesterol, LDL-C, LDL/HDL-C ratio and BMI. Several genetic factors account for the variation in cholesterol levels and obesity indices, however, we believe that the possibilities of genetic differences between the two groups are minimal since the population of Crete is stable with a long history over 4000 years. In addition to this, the ApoE genotype distribution found no differences between the two groups (fasters vs controls). In the fasters' group the mean decrease within all three fasting periods was 9% for total cholesterol and 12% for LDL-C. However, it was observed that during non-fasting periods when fasters returned to their usual dietary habits, total cholesterol and LDL-C increased by 6% and 9% respectively. This shows that the reduced end-total and LDL cholesterol concentrations that were observed within the fasting periods were not sustained when the subjects returned to their usual dietary habits even though the increase did not reach the initial pre- levels. The reduction in HDL that occurred in fasters is a common finding with low-fat and vegetarian diets [2831]. The findings above are in agreement with the results reported by Barnard et al who conducted a strict vegetarian-diet intervention study for 5 weeks on 35 women [30]. The intervention diet consisted of grains, legumes, vegetables and fruit. After the intervention diet phase total cholesterol, LDL and HDL were decreased by 13.2%, 16.9% and 16.5% respectively [30]. BMI was also significantly reduced (p < 0.001) while, in agreement with our findings, the TC/HDL and LDL/HDL ratios remained unchanged (table 5)[30]. Similar were the findings in another 6-week vegetarian-diet intervention study by Masarei et al [28] and in a 12-week low-fat-vegan-diet intervention study by Nicholson et al [32]. Lee [33] and Hoffman [34], who compared omnivores with lacto-ovo-vegetarians, found no difference in LDL/HDL ratio between the two groups. The contrasting results on LDL/HDL ratio could be attributed to differences in the population samples studied.
Nieman et al [14] and Toohey et al [35] investigated Seventh-Day Adventists with similar demographic and life-style factors and with comparable diets and dietary habits to our cohort. They found that lacto-ovo-vegetarians and lifetime strict vegetarians had lower concentrations of total and LDL cholesterol when compared with non-vegetarians and lacto-ovo-vegetarians respectively (p < 0.05) [14]. Toohey et al found also found lower levels of BMI, triacylglycerols and TC/HDL ratio [35]. The present study showed that women had lower levels of LDL/HDL ratio and TC/HDL ratio, which is also a better predictor for CHD in women [3638]. This is explained by the higher concentrations of HDL that women have compared to men [39].
The positive association of waist-to-hip ratio with total and LDL cholesterol is in agreement with other studies that correlate waist-to-hip ratio with coronary risk factors and CHD prevalence [4042]. Waist-to-hip ratio measurement is a simple and cost-effective measure that contributes in predicting abnormal lipoprotein levels and increased risk of cardiovascular disease.
Both the fasting and control groups had mean BMI in the overweight category. Fasting had a small but statistically significant impact on fasters' BMI at the end of the fasting periods that was not sustained in non-fasting periods. In accordance to the results in this study, Haddad et al studying a group of vegans and nonvegetarians found significantly lower BMI levels in the vegan group [43]. Moreover, others found that vegetarians have lower BMI than meat eaters [4446]. At the same time following a Mediterranean-style diet has also been proven to be beneficial to weight loss [47]. As regards religious fasting some studies associate it with weight loss and decline in BMI [2, 3] while others do not [4, 5, 48].
Educational level was not found to influence any of the blood lipid variables in this study (Table 3). This was an unexpected result since higher education is associated with better health care and awareness whereas low educational level has been related to unfavorable lipid profile [49], all-cause and CAD mortality [50] and hypertension [51].
The beneficial changes seen in fasters diet during the fasting periods, especially regarding energy intake, total fat and fiber consumption, can also explain the reductions in the biochemical and obesity indices. A recent study of the University of Crete showed that the Christian Orthodox nuns' diet was very low in cholesterol and in saturated fat intake (6% of total energy intake), and high in fiber and antioxidant vitamins [16]. This could be attributed to nuns' high consumption of fruit, vegetables, cereals and legumes. In another study Haddad et al found that vegans consume more grains, vegetables, fruit, legumes and seeds and as a result their diet consists of more dietary fiber and less dietary cholesterol [43]. It is well known that reduced intakes of dietary SFA and cholesterol lower total and LDL cholesterol concentration and are associated with low risk of cardiovascular diseases [52, 53]. The Orthodox Christians' diet, which is based on vegetables, legumes, fruit, cereals, bread and olive oil, is a Mediterranean-type of diet with periodic abstinence from meat and other animal products during the fasting periods. Numerous investigators [5456] have recognized the beneficial role of the Mediterranean diet in cardiovascular diseases, and the protective effect in terms of cancer and longevity have also been noted [57, 58]. In addition, supplementary studies have associated religiosity with good health [10]. This has been confirmed in a recent study by Chliaoutakis et al [59], which is the only published work to date which investigates the association between the Orthodox Christian lifestyle and health. Chliaoutakis et al found that devout Orthodox Christians adopt healthier life-styles and that religion has a substantial impact on mental and physical health-related behaviors [59]. In the present study, contrary to Chliaoutakis' findings, the physical activity of the two groups (fasters vs controls) did not differ in any of the testing periods.
Our study attempts to provide an understanding of the impact of Christian Orthodox fasting on serum blood lipids and obesity indices before and at the end of the three major fasting periods. Compared to controls, fasters presented decreased lipoproteins and BMI levels. These results support our hypothesis by highlighting the beneficial influence of Christian Orthodox fasting on lipoprotein profile and prevalence of obesity.

Acknowledgments

We appreciate the assistance of Bishop Nektarios of Crete in supporting the study and the Monasteries of Sabbathiana, Isodia Theotokou and Kremaston for their participation. We are also grateful to Dr N.Yiannakouris, Mrs C.Codrington, Dr C.Hatzis, Ms F.Bervanaki, Mr M.Kiriakakis and Mr G.Tsibinos.

Competing interests

None declared.

Authors' contributions

Author K.S mainly organized and performed the study, and drafted the manuscript. Author N.T participated in the design of the study and supervised the manuscript. Author M.L performed the statistical analyses. Author G.M performed part of the statistical analysis. Author A.K conceived of the study, participated in its design, and supervised the study and the manuscript.
Literatur
1.
Zurück zum Zitat Shatenstein B, Ghadirian P: Influences on diet, health behaviours and their outcome in select ethnocultural and religious groups. Nutrition. 1998, 14 (2): 223-30. 10.1016/S0899-9007(97)00425-5.CrossRefPubMed Shatenstein B, Ghadirian P: Influences on diet, health behaviours and their outcome in select ethnocultural and religious groups. Nutrition. 1998, 14 (2): 223-30. 10.1016/S0899-9007(97)00425-5.CrossRefPubMed
2.
Zurück zum Zitat Temizhan A, et al: The effects of Ramadan fasting on blood lipid levels. Am J Med. 2000, 109 (4): 341-2. 10.1016/S0002-9343(00)00498-8.CrossRefPubMed Temizhan A, et al: The effects of Ramadan fasting on blood lipid levels. Am J Med. 2000, 109 (4): 341-2. 10.1016/S0002-9343(00)00498-8.CrossRefPubMed
3.
Zurück zum Zitat Adlouni A, et al: Fasting during Ramadan induces a marked increase in high-density lipoprotein cholesterol and decrease in low-density lipoprotein cholesterol. Ann Nutr Metab. 1997, 41 (4): 242-9.CrossRefPubMed Adlouni A, et al: Fasting during Ramadan induces a marked increase in high-density lipoprotein cholesterol and decrease in low-density lipoprotein cholesterol. Ann Nutr Metab. 1997, 41 (4): 242-9.CrossRefPubMed
4.
Zurück zum Zitat Maislos M, et al: Marked increase in plasma high-density-lipoprotein cholesterol after prolonged fasting during Ramadan. Am J Clin Nutr. 1993, 57 (5): 640-2.PubMed Maislos M, et al: Marked increase in plasma high-density-lipoprotein cholesterol after prolonged fasting during Ramadan. Am J Clin Nutr. 1993, 57 (5): 640-2.PubMed
5.
Zurück zum Zitat Maislos M, et al: Gorging and plasma HDL-cholesterol – the Ramadan model. Eur J Clin Nutr. 1998, 52 (2): 127-30. 10.1038/sj.ejcn.1600526.CrossRefPubMed Maislos M, et al: Gorging and plasma HDL-cholesterol – the Ramadan model. Eur J Clin Nutr. 1998, 52 (2): 127-30. 10.1038/sj.ejcn.1600526.CrossRefPubMed
6.
Zurück zum Zitat Akhan G, Kutluhan S, Koyuncuoglu HR: Is there any change of stroke incidence during Ramadan?. Acta Neurol Scand. 2000, 101 (4): 259-61. 10.1034/j.1600-0404.2000.101004259.x.CrossRefPubMed Akhan G, Kutluhan S, Koyuncuoglu HR: Is there any change of stroke incidence during Ramadan?. Acta Neurol Scand. 2000, 101 (4): 259-61. 10.1034/j.1600-0404.2000.101004259.x.CrossRefPubMed
7.
Zurück zum Zitat Temizhan A, et al: Is there any effect of Ramadan fasting on acute coronary heart disease events?. Int J Cardiol. 1999, 70 (2): 149-53. 10.1016/S0167-5273(99)00082-0.CrossRefPubMed Temizhan A, et al: Is there any effect of Ramadan fasting on acute coronary heart disease events?. Int J Cardiol. 1999, 70 (2): 149-53. 10.1016/S0167-5273(99)00082-0.CrossRefPubMed
8.
Zurück zum Zitat Akanji AO, Mojiminiyi OA, Abdella N: Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait. Eur J Clin Nutr. 2000, 54 (6): 508-13. 10.1038/sj.ejcn.1601047.CrossRefPubMed Akanji AO, Mojiminiyi OA, Abdella N: Beneficial changes in serum apo A-1 and its ratio to apo B and HDL in stable hyperlipidaemic subjects after Ramadan fasting in Kuwait. Eur J Clin Nutr. 2000, 54 (6): 508-13. 10.1038/sj.ejcn.1601047.CrossRefPubMed
9.
Zurück zum Zitat Friedlander Y, et al: Coronary heart disease risk factors among religious groupings in a Jewish population sample in Jerusalem. Am J Clin Nutr. 1985, 42 (3): 511-21.PubMed Friedlander Y, et al: Coronary heart disease risk factors among religious groupings in a Jewish population sample in Jerusalem. Am J Clin Nutr. 1985, 42 (3): 511-21.PubMed
10.
Zurück zum Zitat Friedlander Y, Kark JD, Stein Y: Religious observance and plasma lipids and lipoproteins among 17-year-old Jewish residents of Jerusalem. Prev Med. 1987, 16 (1): 70-9.CrossRefPubMed Friedlander Y, Kark JD, Stein Y: Religious observance and plasma lipids and lipoproteins among 17-year-old Jewish residents of Jerusalem. Prev Med. 1987, 16 (1): 70-9.CrossRefPubMed
11.
Zurück zum Zitat Fraser GE: Associations between diet and cancer, ischemic heart disease, and all- cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr. 1999, 70 (3 Suppl): 532S-538S.PubMed Fraser GE: Associations between diet and cancer, ischemic heart disease, and all- cause mortality in non-Hispanic white California Seventh-day Adventists. Am J Clin Nutr. 1999, 70 (3 Suppl): 532S-538S.PubMed
12.
Zurück zum Zitat Fraser GE: Diet as primordial prevention in Seventh-Day Adventists. Prev Med. 1999, 29 (6 Pt 2): S18-23. 10.1006/pmed.1998.0415.CrossRefPubMed Fraser GE: Diet as primordial prevention in Seventh-Day Adventists. Prev Med. 1999, 29 (6 Pt 2): S18-23. 10.1006/pmed.1998.0415.CrossRefPubMed
13.
Zurück zum Zitat Famodu AA, et al: Blood pressure and blood lipid levels among vegetarian, semi-vegetarian, and non-vegetarian native Africans. Clin Biochem. 1998, 31 (7): 545-9. 10.1016/S0009-9120(98)00067-8.CrossRefPubMed Famodu AA, et al: Blood pressure and blood lipid levels among vegetarian, semi-vegetarian, and non-vegetarian native Africans. Clin Biochem. 1998, 31 (7): 545-9. 10.1016/S0009-9120(98)00067-8.CrossRefPubMed
14.
Zurück zum Zitat Nieman DC, et al: Dietary status of Seventh-Day Adventist vegetarian and non-vegetarian elderly women. J Am Diet Assoc. 1989, 89 (12): 1763-9.PubMed Nieman DC, et al: Dietary status of Seventh-Day Adventist vegetarian and non-vegetarian elderly women. J Am Diet Assoc. 1989, 89 (12): 1763-9.PubMed
16.
Zurück zum Zitat Kafatos A, et al: Mediterranean diet of Crete: foods and nutrient content. J Am Diet Assoc. 2000, 100 (12): 1487-93. 10.1016/S0002-8223(00)00416-8.CrossRefPubMed Kafatos A, et al: Mediterranean diet of Crete: foods and nutrient content. J Am Diet Assoc. 2000, 100 (12): 1487-93. 10.1016/S0002-8223(00)00416-8.CrossRefPubMed
17.
Zurück zum Zitat Lohman TG, Roche AF, Mastorell R: Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Publishers. 1991 Lohman TG, Roche AF, Mastorell R: Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Publishers. 1991
18.
Zurück zum Zitat Allain CC, et al: Enzymatic determination of total serum cholesterol. Clin Chem. 1974, 20 (4): 470-5.PubMed Allain CC, et al: Enzymatic determination of total serum cholesterol. Clin Chem. 1974, 20 (4): 470-5.PubMed
19.
Zurück zum Zitat Finley PR, et al: Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem. 1978, 24 (6): 931-3.PubMed Finley PR, et al: Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem. 1978, 24 (6): 931-3.PubMed
20.
Zurück zum Zitat Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982, 28 (10): 2077-80.PubMed Fossati P, Prencipe L: Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982, 28 (10): 2077-80.PubMed
21.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18 (6): 499-502.PubMed
22.
Zurück zum Zitat Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16 (3): 1215-CrossRefPubMedPubMedCentral Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16 (3): 1215-CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Reymer PW, et al: Apolipoprotein E genotyping on agarose gels. Clin Chem. 1995, 41 (7): 1046-7.PubMed Reymer PW, et al: Apolipoprotein E genotyping on agarose gels. Clin Chem. 1995, 41 (7): 1046-7.PubMed
24.
Zurück zum Zitat Ordovas JM: The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc. 1999, 58 (1): 171-87.CrossRefPubMed Ordovas JM: The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc. 1999, 58 (1): 171-87.CrossRefPubMed
25.
Zurück zum Zitat Dreon DM, Krauss RM: Diet-gene interactions in human lipoprotein metabolism. J Am Coll Nutr. 1997, 16 (4): 313-24.CrossRefPubMed Dreon DM, Krauss RM: Diet-gene interactions in human lipoprotein metabolism. J Am Coll Nutr. 1997, 16 (4): 313-24.CrossRefPubMed
26.
Zurück zum Zitat Lopez-Miranda J, et al: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994, 35 (11): 1965-75.PubMed Lopez-Miranda J, et al: Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994, 35 (11): 1965-75.PubMed
27.
Zurück zum Zitat Miettinen TA, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet. 1988, 2 (8622): 1261-10.1016/S0140-6736(88)90862-8.CrossRefPubMed Miettinen TA, Gylling H, Vanhanen H: Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet. 1988, 2 (8622): 1261-10.1016/S0140-6736(88)90862-8.CrossRefPubMed
28.
Zurück zum Zitat Masarei JR, et al: Vegetarian diets, lipids and cardiovascular risk. Aust N Z J Med. 1984, 14 (4): 400-4.CrossRefPubMed Masarei JR, et al: Vegetarian diets, lipids and cardiovascular risk. Aust N Z J Med. 1984, 14 (4): 400-4.CrossRefPubMed
29.
Zurück zum Zitat Masarei JR, et al: Effects of a lacto-ovo vegetarian diet on serum concentrations of cholesterol, triglyceride, HDL-C, HDL2-C, HDL3-C, apoprotein-B, and Lp(a). Am J Clin Nutr. 1984, 40 (3): 468-78.PubMed Masarei JR, et al: Effects of a lacto-ovo vegetarian diet on serum concentrations of cholesterol, triglyceride, HDL-C, HDL2-C, HDL3-C, apoprotein-B, and Lp(a). Am J Clin Nutr. 1984, 40 (3): 468-78.PubMed
30.
Zurück zum Zitat Barnard ND, et al: Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women. Am J Cardiol. 2000, 85 (8): 969-72. 10.1016/S0002-9149(99)00911-X.CrossRefPubMed Barnard ND, et al: Effectiveness of a low-fat vegetarian diet in altering serum lipids in healthy premenopausal women. Am J Cardiol. 2000, 85 (8): 969-72. 10.1016/S0002-9149(99)00911-X.CrossRefPubMed
31.
Zurück zum Zitat Asztalos B, et al: Differential response to low-fat diet between low and normal HDL-cholesterol subjects. J Lipid Res. 2000, 41 (3): 321-8.PubMed Asztalos B, et al: Differential response to low-fat diet between low and normal HDL-cholesterol subjects. J Lipid Res. 2000, 41 (3): 321-8.PubMed
32.
Zurück zum Zitat Nicholson AS, et al: Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med. 1999, 29 (2): 87-91. 10.1006/pmed.1999.0529.CrossRefPubMed Nicholson AS, et al: Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet. Prev Med. 1999, 29 (2): 87-91. 10.1006/pmed.1999.0529.CrossRefPubMed
33.
Zurück zum Zitat Lee HY, et al: Serum fatty acid, lipid profile and dietary intake of Hong Kong Chinese omnivores and vegetarians. Eur J Clin Nutr. 2000, 54 (10): 768-73. 10.1038/sj.ejcn.1601089.CrossRefPubMed Lee HY, et al: Serum fatty acid, lipid profile and dietary intake of Hong Kong Chinese omnivores and vegetarians. Eur J Clin Nutr. 2000, 54 (10): 768-73. 10.1038/sj.ejcn.1601089.CrossRefPubMed
34.
Zurück zum Zitat Hoffmann I, et al: Giessen Wholesome Nutrition Study: relation between a health-conscious diet and blood lipids. Eur J Clin Nutr. 2001, 55 (10): 887-95. 10.1038/sj.ejcn.1601243.CrossRefPubMed Hoffmann I, et al: Giessen Wholesome Nutrition Study: relation between a health-conscious diet and blood lipids. Eur J Clin Nutr. 2001, 55 (10): 887-95. 10.1038/sj.ejcn.1601243.CrossRefPubMed
35.
Zurück zum Zitat Toohey ML, et al: Cardiovascular disease risk factors are lower in African-American vegans compared to lacto-ovo-vegetarians. J Am Coll Nutr. 1998, 17 (5): 425-34.CrossRefPubMed Toohey ML, et al: Cardiovascular disease risk factors are lower in African-American vegans compared to lacto-ovo-vegetarians. J Am Coll Nutr. 1998, 17 (5): 425-34.CrossRefPubMed
36.
Zurück zum Zitat Wang TD, et al: Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am J Cardiol. 2001, 88 (7): 737-43. 10.1016/S0002-9149(01)01843-4.CrossRefPubMed Wang TD, et al: Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population. Am J Cardiol. 2001, 88 (7): 737-43. 10.1016/S0002-9149(01)01843-4.CrossRefPubMed
37.
Zurück zum Zitat Solymoss BC, et al: Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol. 1993, 72 (17): 1215-9.CrossRefPubMed Solymoss BC, et al: Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol. 1993, 72 (17): 1215-9.CrossRefPubMed
38.
Zurück zum Zitat Hong MK, et al: Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol. 1991, 68 (17): 1646-50.CrossRefPubMed Hong MK, et al: Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women. Am J Cardiol. 1991, 68 (17): 1646-50.CrossRefPubMed
39.
Zurück zum Zitat Price JF, et al: Influence of high-density lipoprotein cholesterol and rheological factors on the sex difference in cardiovascular disease. J Cardiovasc Risk. 2000, 7 (1): 49-56.CrossRefPubMed Price JF, et al: Influence of high-density lipoprotein cholesterol and rheological factors on the sex difference in cardiovascular disease. J Cardiovasc Risk. 2000, 7 (1): 49-56.CrossRefPubMed
40.
Zurück zum Zitat Onat A, Sansoy V, Uysal O: Waist circumference and waist-to-hip ratio in Turkish adults: interrelation with other risk factors and association with cardiovascular disease. Int J Cardiol. 1999, 70 (1): 43-50. 10.1016/S0167-5273(99)00049-2.CrossRefPubMed Onat A, Sansoy V, Uysal O: Waist circumference and waist-to-hip ratio in Turkish adults: interrelation with other risk factors and association with cardiovascular disease. Int J Cardiol. 1999, 70 (1): 43-50. 10.1016/S0167-5273(99)00049-2.CrossRefPubMed
41.
Zurück zum Zitat Mansfield E, McPherson R, Koski KG: Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease. J Am Diet Assoc. 1999, 99 (11): 1373-9. 10.1016/S0002-8223(99)00335-1.CrossRefPubMed Mansfield E, McPherson R, Koski KG: Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease. J Am Diet Assoc. 1999, 99 (11): 1373-9. 10.1016/S0002-8223(99)00335-1.CrossRefPubMed
42.
Zurück zum Zitat Perry AC, et al: Clinical predictability of the waist-to-hip ratio in assessment of cardiovascular disease risk factors in overweight, premenopausal women. Am J Clin Nutr. 1998, 68 (5): 1022-7.PubMed Perry AC, et al: Clinical predictability of the waist-to-hip ratio in assessment of cardiovascular disease risk factors in overweight, premenopausal women. Am J Clin Nutr. 1998, 68 (5): 1022-7.PubMed
43.
Zurück zum Zitat Haddad EH, et al: Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am J Clin Nutr. 1999, 70 (3 Suppl): 586S-593S.PubMed Haddad EH, et al: Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians. Am J Clin Nutr. 1999, 70 (3 Suppl): 586S-593S.PubMed
44.
Zurück zum Zitat Burr ML, Butland BK: Heart disease in British vegetarians. Am J Clin Nutr. 1988, 48 (3 Suppl): 830-2.PubMed Burr ML, Butland BK: Heart disease in British vegetarians. Am J Clin Nutr. 1988, 48 (3 Suppl): 830-2.PubMed
45.
Zurück zum Zitat Key TJ, Davey GK, Appleby PN: Health benefits of a vegetarian diet. Proc Nutr Soc. 1999, 58 (2): 271-5.CrossRefPubMed Key TJ, Davey GK, Appleby PN: Health benefits of a vegetarian diet. Proc Nutr Soc. 1999, 58 (2): 271-5.CrossRefPubMed
47.
Zurück zum Zitat De Lorenzo A, et al: Effects of weight loss on body composition and pulmonary function. Respiration. 1999, 66 (5): 407-12. 10.1159/000029423.CrossRefPubMed De Lorenzo A, et al: Effects of weight loss on body composition and pulmonary function. Respiration. 1999, 66 (5): 407-12. 10.1159/000029423.CrossRefPubMed
48.
Zurück zum Zitat el Ati J, Beji C, Danguir J: Increased fat oxidation during Ramadan fasting in healthy women: an adaptative mechanism for body-weight maintenance. Am J Clin Nutr. 1995, 62 (2): 302-7.PubMed el Ati J, Beji C, Danguir J: Increased fat oxidation during Ramadan fasting in healthy women: an adaptative mechanism for body-weight maintenance. Am J Clin Nutr. 1995, 62 (2): 302-7.PubMed
49.
Zurück zum Zitat Verschuren WM, Boerma GJ, Kromhout D: Total and HDL-cholesterol in The Netherlands: 1987–1992. Levels and changes over time in relation to age, gender and educational level. Int J Epidemiol. 1994, 23 (5): 948-56.CrossRefPubMed Verschuren WM, Boerma GJ, Kromhout D: Total and HDL-cholesterol in The Netherlands: 1987–1992. Levels and changes over time in relation to age, gender and educational level. Int J Epidemiol. 1994, 23 (5): 948-56.CrossRefPubMed
50.
Zurück zum Zitat Hardarson T, et al: The relationship between educational level and mortality. The Reykjavik Study. J Intern Med. 2001, 249 (6): 495-502. 10.1046/j.1365-2796.2001.00834.x.CrossRefPubMed Hardarson T, et al: The relationship between educational level and mortality. The Reykjavik Study. J Intern Med. 2001, 249 (6): 495-502. 10.1046/j.1365-2796.2001.00834.x.CrossRefPubMed
51.
Zurück zum Zitat Tedesco MA, et al: Educational level and hypertension: how socioeconomic differences condition health care. J Hum Hypertens. 2001, 15 (10): 727-31. 10.1038/sj.jhh.1001249.CrossRefPubMed Tedesco MA, et al: Educational level and hypertension: how socioeconomic differences condition health care. J Hum Hypertens. 2001, 15 (10): 727-31. 10.1038/sj.jhh.1001249.CrossRefPubMed
52.
Zurück zum Zitat Law M: Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach. Am J Clin Nutr. 2000, 72 (5 Suppl): 1291S-1296S.PubMed Law M: Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach. Am J Clin Nutr. 2000, 72 (5 Suppl): 1291S-1296S.PubMed
53.
Zurück zum Zitat Shahar DR, et al: Seasonal variations in dietary intake affect the consistency of dietary assessment. Eur J Epidemiol. 2001, 17 (2): 129-33. 10.1023/A:1017542928978.CrossRefPubMed Shahar DR, et al: Seasonal variations in dietary intake affect the consistency of dietary assessment. Eur J Epidemiol. 2001, 17 (2): 129-33. 10.1023/A:1017542928978.CrossRefPubMed
54.
Zurück zum Zitat Kafatos A, et al: Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 y: the Seven Countries Study. Am J Clin Nutr. 1997, 65 (6): 1882-6.PubMed Kafatos A, et al: Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 y: the Seven Countries Study. Am J Clin Nutr. 1997, 65 (6): 1882-6.PubMed
55.
Zurück zum Zitat Panagiotakos DB, et al: The association of Mediterranean diet with lower risk of acute coronary syndromes in hypertensive subjects. Int J Cardiol. 2002, 82 (2): 141-7. 10.1016/S0167-5273(01)00611-8.CrossRefPubMed Panagiotakos DB, et al: The association of Mediterranean diet with lower risk of acute coronary syndromes in hypertensive subjects. Int J Cardiol. 2002, 82 (2): 141-7. 10.1016/S0167-5273(01)00611-8.CrossRefPubMed
56.
Zurück zum Zitat Kris-Etherton P, et al: AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation. 2001, 103 (13): 1823-5.CrossRefPubMed Kris-Etherton P, et al: AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation. 2001, 103 (13): 1823-5.CrossRefPubMed
57.
Zurück zum Zitat Trichopoulou A, Vasilopoulou E: Mediterranean diet and longevity. Br J Nutr. 2000, 84 (Suppl 2): S205-9.CrossRefPubMed Trichopoulou A, Vasilopoulou E: Mediterranean diet and longevity. Br J Nutr. 2000, 84 (Suppl 2): S205-9.CrossRefPubMed
58.
Zurück zum Zitat Trichopoulou A, et al: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000, 9 (9): 869-73.PubMed Trichopoulou A, et al: Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000, 9 (9): 869-73.PubMed
59.
Zurück zum Zitat Chliaoutakis JE, et al: Greek christian orthodox ecclesiastical lifestyle: could it become a pattern of health-related behavior?. Prev Med. 2002, 34 (4): 428-35. 10.1006/pmed.2001.1001.CrossRefPubMed Chliaoutakis JE, et al: Greek christian orthodox ecclesiastical lifestyle: could it become a pattern of health-related behavior?. Prev Med. 2002, 34 (4): 428-35. 10.1006/pmed.2001.1001.CrossRefPubMed
Metadaten
Titel
Effects of Greek orthodox christian church fasting on serum lipids and obesity
verfasst von
Katerina O Sarri
Nikolaos E Tzanakis
Manolis K Linardakis
George D Mamalakis
Anthony G Kafatos
Publikationsdatum
01.12.2003
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2003
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-3-16

Weitere Artikel der Ausgabe 1/2003

BMC Public Health 1/2003 Zur Ausgabe